Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00221247 · ClinicalTrials.gov registry record · Phase 2

Acupuncture as Complementary Therapy for Cerebral Palsy

A Phase 2 study of Cerebral Palsy, sponsored by University of Arizona.

Completed
Registry status
Phase 2
Development phase
75
Enrollment target
2
Study locations

NCT00221247: Completed Phase 2 study of Cerebral Palsy, sponsored by University of Arizona.

NCT00221247 is a Phase 2 study of Cerebral Palsy that has completed, run by University of Arizona. The registered enrollment target is 75 participants, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (67% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00221247, a Phase 2 study of Cerebral Palsy, has completed, sponsored by University of Arizona.

COMPLETED
Registry status
Phase 2
Development phase
75 participants
Enrollment target
2
Study locations

Study Summary

Background: Cerebral palsy (CP) is the most frequent cause of childhood disability in the US. Nevertheless, current standard of care for CP in the U.S. is to a large extent ineffective. The Chinese, on the other hand, claim to have an exceptionally high response rate with the administration of an integrated package of care that includes the combination of intense 'conventional' therapies and acupuncture. Despite numerous anecdotal reports, this claim has not yet been tested in a rigorous scientific way. Objective: To determine the effectiveness of acupuncture when used as an adjunct to intense 'conventional' physical, occupational, and hydro- therapies to improve function and quality of life in children with spastic CP. Hypotheses: (1) Adjunctive acupuncture therapy will improve the gross and fine motor function and the health related quality of life of children with spastic CP more than intense 'conventional' therapies alone. (2) The level of persistence of gross and fine motor function and health related quality of life achieved with adjunctive acupuncture administered in combination with intense 'conventional' therapies will be higher than those achieved with intense 'conventional' therapies alone. Design: A parallel, two-arm, prospective, evaluation-blind, pragmatic, non-inferiority, randomized controlled clinical trial (RCT). Setting: This international collaborative study will be conducted at two different localities: (1) At the Beijing Children's Hospital (BCH), where participants' recruitment, intervention therapies, videotape evaluation, and data collection will be done, and (2) At the University of Arizona, where scoring of the videotape evaluations and data analyses will be done, and from where logistic support will be provided to assure the scientific integrity of the study. Population: Approximately 100 children between the ages 1 and 6 years with spastic CP. Intervention: Concurrent administration of acupuncture with intense 'conventional' therapies at

Conditions Studied

Interventions

  • PROCEDURE Acupuncture

Study Locations (2)

Arizona

  • The University of Arizona, Department of Pediatrics - Tucson

Beijing Municipality

  • Beijing Children's Hospital - Beijing

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2004-10
Est. Completion 2008-10
Phase Phase 2
University of Arizona

349 total trials

What the finished NCT00221247 record still lists

NCT00221247 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 229-participant average among 91 other Cerebral Palsy trials with a reported enrollment target (67% lower).

The record links to 1 condition, with Cerebral Palsy appearing as the primary indexed condition, and to 1 intervention - of which Acupuncture is the first listed.

NCT00221247 reports a single indexed study location in Arizona, Beijing Municipality.

Frequently Asked Questions

What is clinical trial NCT00221247 about?

NCT00221247 is a clinical study titled "Acupuncture as Complementary Therapy for Cerebral Palsy". Background: Cerebral palsy (CP) is the most frequent cause of childhood disability in the US. Nevertheless, current standard of care for CP in the U.S. is to a large extent ineffective. The Chinese, on the other hand, claim to have an exceptionally high response rate with the administration of an in...

What is the current status of trial NCT00221247?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 75 participants. The study started on 2004-10. Estimated completion is 2008-10.

What conditions does trial NCT00221247 study?

This clinical trial studies the following conditions: Cerebral Palsy.

What interventions are being tested in trial NCT00221247?

The interventions under investigation include: Acupuncture (PROCEDURE).

Who is sponsoring clinical trial NCT00221247?

This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00221247 being conducted?

This trial has 2 study locations across Arizona, Beijing Municipality. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cerebral Palsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00221247's enrollment target sits among peer trials

75 31st of 91 higher than 61 of 91 other Cerebral Palsy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cerebral Palsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00221247, the US trial registry maintained by the National Library of Medicine. NCT00221247 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.